A Win For Kintara Therapeutics Inc.
Thu, Dec 01, 2022 at 07:07 PM
Kintara Therapeutics Inc. (KTRA:NASDAQ) shot up at $8.86, representing a gain of 32.2%. On Thu, Dec 01, 2022, KTRA:NASDAQ touched a New 2-Week High of $8.86. The stock appeared on our News Catalysts scanner on Thu, Dec 01, 2022 at 08:15 AM in the 'MISCELLANEOUS' category. From Thu, Nov 17, 2022, the stock recorded 77.78% Up Days and 70.00% Green Days
About Kintara Therapeutics Inc. (KTRA:NASDAQ)
Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs.
Top 10 Gainers:
- Vapotherm, Inc. (VAPO:NYSE), 51.69%
- Neonode Inc. (NEON:NASDAQ), 44.63%
- Conformis, Inc. (CFMS:NASDAQ), 35%
- Kintara Therapeutics Inc. (KTRA:NASDAQ), 32.24%
- Trinity Place Holdings Inc. (TPHS:NYSEMKT), 30.66%
- Ra Medical Systems, Inc. (RMED:NYSE), 29.39%
- Sonim Technologies, Inc. (SONM:NASDAQ), 29.08%
- Portage Biotech Inc. (PRTG:NASDAQ), 26.53%
- Okta, Inc. (OKTA:NASDAQ), 26.46%
- Arco Platform Limited (ARCE:NASDAQ), 25.77%